Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma In a double-blind, randomized, controlled trial, 34 participants with established MRONJ, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results